Contact Info
scousino@englandco.com (202) 386-6504Office
Washington, DC
1650 Tysons Boulevard
Suite 800
McLean, VA 22102
Scott R. Cousino
Senior Advisor
Scott Cousino has over 30 years of investment banking experience primarily focused on the healthcare sector where he has completed a wide range of M&A, strategic advisory, and capital markets transactions.
Prior to joining England & Company in 2013, Mr. Cousino was a Managing Director at Stifel Nicolaus Weisel, where he had served as Head of its Healthcare Investment Banking Group. He also served as a Managing Director and Head of Healthcare Investment Banking at Legg Mason prior to its acquisition by Stifel in 2005. In addition, Mr. Cousino served as Chairman of the Fairness Opinion Committee at Stifel and Legg Mason for over ten years.
Mr. Cousino earned his BBA and MBA in Finance from the College of William and Mary. He has been active on numerous non-profit boards and currently serves on the Finance Committee of the Y of Central Maryland.
Sector Specialities:
- Healthcare
SELECTED TRANSACTION
Carefirst Made Strategic Investment in Sharecare
January 2018 – CareFirst BlueCross BlueShield, through an affiliate, recently made a strategic investment in Sharecare, Inc. England Securities served as financial advisor to CareFirst in connection with the structuring of this investment. CareFirst also signed a contract with Sharecare to provide CareFirst members with comprehensive wellness and disease management services, beginning in 2019.
Sharecare is the digital health company that helps people manage all their health in one place. The Sharecare platform provides each person – no matter where they are in their health journey – with a comprehensive and personalized health profile, where they can dynamically and easily connect to the information, evidence-based programs and health professionals they need to live their healthiest, happiest and most productive life. In addition to providing individual consumers with direct access to award-winning and innovative frictionless technologies, scientifically validated clinical protocols and best-in-class coaching tools, Sharecare also helps providers, employers and health plans effectively scale outcomes-based health and wellness solutions across their entire populations.
CareFirst BlueCross BlueShield, based in Baltimore, MD, is an independent licensee of the Blue Cross and Blue Shield Association. Through its affiliates and subsidiaries, CareFirst BlueCross BlueShield offers a comprehensive portfolio of health insurance products and administrative services to 3.4 million individuals and groups in Maryland, the District of Columbia and Northern Virginia.
CareFirst Holdings enters into a Strategic Partnership with Exosome Diagnostics
August 2017 – CareFirst BlueCross BlueShield, through an affiliate, recently entered into a strategic partnership with Exosome Diagnostics, Inc. England Securities served as financial advisor to CareFirst BlueCross BlueShield in connection with the structuring of this partnership.
Exosome Diagnostics is a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. The company’s novel exosome-based technology platform, ExoLution™, and point of care instrument for protein capture and analysis, Shahky™, can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are diagnosed, treated and monitored.
CareFirst BlueCross BlueShield, based in Baltimore, MD, is an independent licensee of the Blue Cross and Blue Shield Association. Through its affiliates and subsidiaries, CareFirst BlueCross BlueShield offers a comprehensive portfolio of health insurance products and administrative services to 3.4 million individuals and groups in Maryland, the District of Columbia and Northern Virginia.
Healthify $2M Seed Round Preferred Stock
CareFirst BlueCross BlueShield sold Medicare Part D Membership to CVS Caremark